shutterstock_1642412275_RETOUCHED_2_edit

Investing in AOA is investing in the future of women's healthcare.

Our Vision and Mission

Our vision is to bring innovative, impactful and cost effective medical technologies from research and development into the hands of patients and providers.

 

Our mission is to change the cancer diagnostic process, starting by bringing to market the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers. 

The AOA team has worked in many diagnostic and medical device markets globally and demonstrated success through the understanding of each healthcare system.

AOADxDec2021-49.jpg

Oriana Papin-Zoghbi

CEO & Co-Founder

OUR TEAM

The co-founders have worked together for over 8 years, combining 30 years of experience bringing products from concept to commercialization across global markets

AOADxDec2021-7_edited_edited.jpg
anna pic.jpg

Anna Jeter

CDO & Co-Founder

Alexander Fisher

COO & Co-Founder